AVLSA
Atlas Venture Life Science Advisors Portfolio holdings
AUM
$662M
1-Year Est. Return
6.63%
1 Year Est. Return
+6.63%
AUM
$662M
AUM Growth
+$141M
(+27%)
Holding
13
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kymera Therapeutics
KYMR
$4.14B
| $214M | 32.26% |
4,896,462
|
|
||
2
Disc Medicine
IRON
$3.14B
| $126M | 19.07% |
2,384,456
|
|
||
3
Dyne Therapeutics
DYN
$2.35B
| $86.9M | 13.12% |
9,130,465
|
|
||
|
SION
4
Sionna Therapeutics
SION
$1.42B
| $64.1M | 9.68% |
3,694,020
|
|
||
|
THRD
5
DELISTED
Third Harmonic Bio
THRD
| $56.5M | 8.53% |
10,402,286
|
|
||
|
VIGL
6
DELISTED
Vigil Neuroscience
VIGL
| $46.4M | 7.01% |
5,836,874
|
|
||
7
Day One Biopharmaceuticals
DAWN
$741M
| $41.8M | 6.31% |
6,430,257
|
|
||
8
Korro Bio
KRRO
$389M
| $14.2M | 2.14% |
1,137,149
|
|
||
|
IMA
9
ImageneBio Inc
IMA
$84.4M
| $6.72M | 1.02% |
418,182
|
|
||
10
Q32 Bio
QTTB
$38.4M
| $3.12M | 0.47% |
2,092,106
|
|
||
11
Generation Bio
GBIO
$42.4M
| $2.65M | 0.4% |
827,948
|
|
||
|
JBIO
12
Jade Biosciences
JBIO
$421M
| – | – |
-51,407
|
|
||
13
Spero Therapeutics
SPRO
$125M
| – | – |
-305,255
|
|